GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...
According to a report by BMI, a subsidiary of Fitch Solutions, the naira’s value is predicted to continue falling, dropping ...
GlobalData on MSN5d
GSK gains approval in Japan for extended indication of RSV vaccineGlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...
In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.90. The company’s shares opened today at ...
It is no wonder then that we had a situation earlier in the year where a company as well-reputed as GlaxoSmithKline had a ...
We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...
North America Leads in Revenue Share with Robust Immunization Infrastructure while Asia-Pacific Drives Fastest Growth Fueled ...
Me was once the darling of DNA testing, but now the ‘spit parties’ are over. After a colossal data breach, its board walked ...
Expansion into Emerging Markets with High Prevalence of Chronic Inflammatory Conditions Presenting Lucrative Opportunities ...
PRNewswire New Delhi [India] November 28 The Organisation of Pharmaceutical Producers of India OPPI organized its flagship ...
Request To Download Sample of This Strategic Report @ Rising cases of thyroid cancer is expected to drive the market. According to National Cancer Institute about 1.2% of men and women are detected ...
With the pharmaceutical industry aiming to grow from $58 billion to $130 billion by 2030, he highlighted significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback